Seattle Genetics (SGEN) Set to Resume Trading at 5:05PM ET

July 14, 2011 4:43 PM EDT
Seattle Genetics (Nasdaq: SGEN) to resume trading at 5:05PM ET after FDA advisory committee in votes in favor of accelerated approval of ADCETRIS.


Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In





Related Categories

FDA, Trading Halts